Biolife Sciences (Biolife Sciences) EV-to-EBIT : -2.72 (As of Jun. 14, 2024)

Biolife Sciences EV-to-EBIT Chart

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
EV-to-EBIT	Get a 7-Day Free Trial										13.89	27.76	31.74	-	-

Competitive Comparison of Biolife Sciences's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Biolife Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biolife Sciences's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolife Sciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Biolife Sciences's EV-to-EBIT falls into.

Biolife Sciences EV-to-EBIT Calculation

Biolife Sciences's EV-to-EBIT for today is calculated as:

Biolife Sciences's current Enterprise Value is $0.32 Mil.
Biolife Sciences's EBIT for the trailing twelve months (TTM) ended in May. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biolife Sciences  (OTCPK:BLFE) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Biolife Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in May. 2008 is calculated as:

Biolife Sciences's Enterprise Value for the quarter that ended in May. 2008 was $3.57 Mil.
Biolife Sciences's EBIT for the trailing twelve months (TTM) ended in May. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biolife Sciences EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description